Skip to main navigation
  • About
    • Our Company
    • Contact
  • Science
    • PIKA Technology Platform
  • Pipeline
    • Our Pipeline
    • Product Candidate
      • Infectious Disease
      • Immuno-Oncology Biotherapeutics
    • Commercial Products
  • Business Development
    • Partnerships
  • Investor Relations
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Board of Directors
      • Management
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
      • Annual Reports
    • Resources
      • Investor FAQs
      • Email Alerts
      • Information Request
      • Contact IR
  • Career
    • Working at Yisheng
Menu
  • About
    • Our Company
    • Contact
  • Science
    • PIKA Technology Platform
  • Pipeline
    • Our Pipeline
    • Product Candidate
      • Infectious Disease
      • Immuno-Oncology Biotherapeutics
    • Commercial Products
  • Business Development
    • Partnerships
  • Investor Relations
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Board of Directors
      • Management
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
      • Annual Reports
    • Resources
      • Investor FAQs
      • Email Alerts
      • Information Request
      • Contact IR
  • Career
    • Working at Yisheng

News Releases

February 16, 2024
/C O R R E C T I O N -- YS Biopharma Co., Ltd./
February 16, 2024
YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting
February 14, 2024
YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance
February 14, 2024
YS Biopharma Announces Appointment of New Directors
February 12, 2024
YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.
February 9, 2024
YS Biopharma Announces US$40 Million Private Placement Financing
January 22, 2024
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
January 8, 2024
YS Biopharma Announces Changes to its Board Committees
Print Page
Email Alerts
RSS Feeds
Contact IR
Site Map Terms of Use Privacy

Contact Info

YS Biopharma Co., Ltd.

11 Firstfield Road Suite A
Gaithersburg, Maryland 20878 USA

Tel: +1 (301) 208 8823
Fax: +1 (301) 208 8827

bjinfo@yishengbio.com

Copyright © 2024 YS Biopharma Co., Ltd.. All Rights Reserved.